Novel MRPS9-ALK Fusion Mutation in a Lung Adenocarcinoma Patient: A Case Report

Anaplastic lymphoma kinase (ALK) rearrangements account for approximately 5–6% of non–small-cell lung cancer (NSCLC) patients. In this study, a case of lung adenocarcinoma harboring a novel MRPS9-ALK fusion is reported. The patient responded well to the first and second generation of ALK-tyrosine ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Huamiao, Xu, Binyue, Xu, Jili, Zhu, Guomeng, Guo, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217641/
https://www.ncbi.nlm.nih.gov/pubmed/34168990
http://dx.doi.org/10.3389/fonc.2021.670907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217641/
https://www.ncbi.nlm.nih.gov/pubmed/34168990
http://dx.doi.org/10.3389/fonc.2021.670907

Ejemplares similares